Riskified Ltd.
NYSE:RSKDSoftware - Application
+$0.02 today
- Market cap
- $890.01M
- Beta
- 1.40
- P/E (TTM)
- -40.1
- EPS (TTM)
- -$0.12
Volume 2.84M
Average 0.90M
RSKD Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Riskified Ltd.NYSE: RSKD
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development dips below year-ago levels
Q1 FY2026 research & development of $17.27M fell 4.5% year over year, behind the +0.1% change in trailing-twelve-month research & development. Sequentially, it rose 1.4% from the prior quarter. Over 3 fiscal years it compounded at -2.2% a year.
Context
- Research & development amounted to 19.6% of revenue in FY2025, down 1.2 pp from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth recovers from -4.5% toward the trailing-twelve-month pace of +0.1%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 67.38M USD
- Year-over-year change
- -1.0%
- 4-year CAGR
- +5.1%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 67.38M | -1.0% |
| FY2024 | 2024-12-31 | 68.07M | -4.9% |
| FY2023 | 2023-12-31 | 71.58M | -0.6% |
| FY2022 | 2022-12-31 | 72.01M | +30.2% |
| FY2021 | 2021-12-31 | 55.3M | — |
Research & Development vs competitors
How RSKD compares with its peers on the latest reported figures
- Peers report in different currencies, so research & development is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of +0.1% is the 6th highest of 9, against a peer median of +2.6%.
- Research & development amounts to 19.5% of revenue for RSKD, versus a peer median of 16.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jun 2026 | CN¥1.01B CNY | +28.6% | -1.5% | 7.9% | |
| LTM Mar 2026 | $105M USD | +2.7% | +18.1% | 22.4% | |
| LTM Mar 2026 | $68.47M USD | +0.1% | -2.2% | 19.5% | |
| LTM Mar 2026 | $66.07M USD | +18.3% | +3.8% | 26.7% | |
| LTM Mar 2026 | $57.52M USD | -15.0% | +12.8% | 16.9% | |
| LTM Mar 2026 | $52.17M USD | +11.2% | +26.5% | 20.8% | |
| LTM Mar 2026 | $40.48M USD | +2.6% | -10.5% | 7.2% | |
| LTM Mar 2026 | $34.74M USD | -11.9% | -38.0% | 27.2% | |
| LTM Mar 2026 | $2.65M USD | — | — | 2.8% | |
| LTM Mar 2026 | $0 USD | -100.0% | — | 0.0% | |
| Peer median (excluding RSKD) | — | +2.6% | +3.8% | 16.9% | |
Competitors are the stored peer set for RSKD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 229.14M | 261.25M | 297.61M | 327.52M | 344.64M |
| Cost of Revenue | 106.17M | 126.15M | 145.09M | 156.58M | 168.66M |
| Gross Profit | 122.97M | 135.1M | 152.52M | 170.94M | 175.98M |
| Gross Margin | 53.7% | 51.7% | 51.2% | 52.2% | 51.1% |
| Research & Development | 55.3M | 72.01M | 71.58M | 68.07M | 67.38M |
| Selling, General & Admin | 123.61M | 172.43M | 157.79M | 150.73M | 137.65M |
| Operating Expenses | 178.91M | 244.45M | 229.37M | 218.79M | 205.03M |
| Depreciation & Amortization | 1.99M | 3.61M | 5.1M | 4.88M | 15.59M |
| EBITDA | (175.88M) | (95.06M) | (48.14M) | (23.62M) | (5.62M) |
| EBITDA Margin | -76.8% | -36.4% | -16.2% | -7.2% | -1.6% |
| Operating Income | (55.94M) | (109.35M) | (76.85M) | (47.85M) | (29.05M) |
| Operating Margin | -24.4% | -41.9% | -25.8% | -14.6% | -8.4% |
| Interest Income | 591K | 10.18M | 22.78M | 20.17M | 13.47M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 |
| Other Income / Expenses | (121.93M) | 10.69M | 23.61M | 19.35M | 7.84M |
| Income Before Tax | (177.87M) | (98.66M) | (53.24M) | (28.5M) | (21.21M) |
| Pre-Tax Margin | -77.6% | -37.8% | -17.9% | -8.7% | -6.2% |
| Income Tax Expense | 1.56M | 6.04M | 5.8M | 6.42M | 6.36M |
| Net Income | (179.43M) | (104.71M) | (59.04M) | (34.92M) | (27.57M) |
| Net Margin | -78.3% | -40.1% | -19.8% | -10.7% | -8.0% |
| EPS (Basic) | (2.34) | (0.62) | (0.33) | (0.20) | (0.18) |
| EPS (Diluted) | (2.34) | (0.62) | (0.33) | (0.20) | (0.18) |
| Weighted Avg Shares | 76.46M | 167.67M | 176.77M | 170.91M | 157.46M |
| Weighted Avg Shares (Diluted) | 76.46M | 167.67M | 176.77M | 170.91M | 157.46M |
Riskified Ltd.
NYSE:RSKD
Intrinsic Alpha fair value
Locked
Current Price
$9.69
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.